Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

• Main Authors: Xutao Sun (Author), Guozhen Chen (Author), Ying Xie (Author), Deyou Jiang (Author), Jieru Han (Author), Fei Chen (Author), Yunjia Song (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context Therapeutic doxorubicin administration is restricted as this anticancer drug may be cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical treatment of chronic heart failure. Objective To explore the protective effects and molecular mechanisms of qiliqiangx...